Arcadia Biosciences Income Statement - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$1.73 $0.03 (1.76%) RKDA stock closing price Oct 24, 2016 (Closing)

Fundamental analysis of RKDA stock involves analyzing its financial statements, apart from checking the Arcadia Biosciences stock price An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the RKDA stock is bound to reflect the impact of the QoQ decline of $0.13M. One also needs to look at Arcadia Biosciences assets, operating expenses and Arcadia Biosciences free cash flow. The profit and loss statement shows revenue of $0.72M for 2016-Q2. Revenue has decreased by $0.13M QoQ for RKDA stock. View details of revenue and profits for Arcadia Biosciences for latest & last 40 quarters.

show more
Get Income statement for another ticker
Fiscal year is Jan - Dec. 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1
Arcadia Biosciences Net Sales or Revenues
Cost Of Goods Sold (COGS)0.03M0.14M0.68M0.06M0.1M0.05M0.07M1.79M0.04M0.09M
Arcadia Biosciences Gross Profit
Research & Development Expense2.21M2.2M1.88M3.17M2.08M1.83M2.08M3.68M2.27M1.98M
Selling General & Admin Expense2.75M3.43M2.89M2.81M2.78M2.63M2.3M1.96M3.98M1.88M
Income Before Depreciation Depletion Amortization-4.28M-4.93M-4.08M-4.23M-3.54M-3.71M-1.64M-5.94M-4.99M-2.58M
Depreciation Depletion Amortization----------
Non Operating Income0.07M0.07M0.67M0.28M0.73M-1.39M0.02M-0.81M0.22M-0.02M
Interest Expense0.32M0.32M0.66M0.76M0.77M0.46M0.36M0.26M0.39M0.38M
Arcadia Biosciences Pretax Income
Provision for Income Taxes0.01M0.01M-0.2M-0.09M0.09M0.22M0.04M0.04M0.09M0.09M
Minority Interest----------
Investment Gains Losses-------0.01M--0.53M-0.39M
Other Income----------
Income Before Extraordinaries & Disc Operations-4.55M-5.19M-3.86M-4.62M-3.68M-5.8M-1.99M-7.06M-5.81M-3.47M
Extraordinary Items & Discontinued Operations----------
Arcadia Biosciences Net Income (Profit/Loss)
Average Shares used to compute Diluted EPS44.31M44.22M44.11M43.65M23.78M2.08M2.07M2.06M2.06M-
Average Shares used to compute Basic EPS44.31M44.22M44.11M43.65M23.78M2.08M2.07M2.06M2.06M-
Income Before Nonrecurring Items-4.55M-5.19M-3.63M-4.62M-3.68M-5.8M-1.99M-7.06M-5.81M-
Income from Nonrecurring Items---0.23M-------
Arcadia Biosciences Earnings Per Share Basic Net
Arcadia Biosciences Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.10-0.12-0.08-0.11-0.19-3.71-1.76-4.19-3.08-
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.

It is very helpful to read a report on Arcadia Biosciences stock analysis. An investor must check the following items in an income statement:
  • Revenue: This is the inflow that is generated from the sale of goods or services and is $0.72M for this quarter of 2016-Q2. Our Arcadia Biosciences revenue chart gives a clear visual representation of how the topline growth has been. Investors often invest in only those companies where the revenue is growing at a steady rate.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. RKDA stock had a poor bottom line growth.
The income statement is also called statement of revenue and expense. The financials along with Arcadia Biosciences historical stock prices provides a lot of details about the firm. .

Arcadia Biosciences Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
Operating margin
Net profit margin
Dividend yield

Other Income Statements - Arcadia Biosciences Inc Industry Peers

Tianli Agritech income statement, The Andersons income statement, Yongye income statement